The challenges and innovations for therapy in children with epilepsy

Nature Reviews Neurology

Volumn 10, Issue 5, 2014, Pages 249-260

  Wilmshurst, Jo M ^a   Berg, Anne T ^b   Lagae, Lieven ^c   Newton, Charles R ^d   Cross, J Helen ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; RUFINAMIDE; SODIUM CHANNEL NAV1.1; STIRIPENTOL;

BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; CHILD; CHILDHOOD ABSENCE EPILEPSY; COGNITIVE DEFECT; COMORBIDITY; DIAGNOSTIC IMAGING; DIET THERAPY; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FOCAL EPILEPSY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL TERMINOLOGY; MORTALITY; MUTATOR GENE; NEUROIMAGING; NEUROSURGERY; OPTOGENETICS; PEDIATRICS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCN1A GENE; SEIZURE; TONIC CLONIC SEIZURE; TREATMENT PLANNING; ANTICONVULSANT THERAPY; DISEASE CLASSIFICATION; DRUG RESPONSE; EPILEPTOGENESIS; GENERALIZED EPILEPSY; INTERVENTION STUDY; LENNOX GASTAUT SYNDROME; NONHUMAN; ONSET AGE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; VAGUS NERVE STIMULATION;

ANTICONVULSANTS; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MUTATION; NAV1.1 VOLTAGE-GATED SODIUM CHANNEL;

EID: 84900866695     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.58     Document Type: Review

References (168)

1. Cross, J. H., Kluger, G. & Lagae, L. Advancing the management of childhood epilepsies. Eur. J. Paediatr. Neurol. 17, 334-347 (2013
2. Mlsna, L. M. & Koh, S. Maturation-dependent behavioral deficits and cell injury in developing animals during the subacute postictal period. Epilepsy Behav. 29, 190-197 (2013
3. Paolicchi, J. M. The timing of pediatric epilepsy syndromes: What are the developmental triggers?. Ann. N. Y. Acad. Sci. 1304, 45-51 (2013
4. Sankar, R. & Rho, J. M. Do seizures affect the developing brain?. Lessons from the laboratory. J. Child Neurol. 22, 21S-29S (2007
5. Holmes, G. L. EEG abnormalities as a biomarker for cognitive comorbidities in pharmacoresistant epilepsy. Epilepsia 54 (Suppl. 2), 60-62 (2013
6. Aldenkamp, A. P. Effect of seizures and epileptiform discharges on cognitive function. Epilepsia 38 (Suppl. 1), S52-S55 (1997
7. Binnie, C. D. Cognitive impairment during epileptiform discharges: Is it ever justifiable to treat the EEG?. Lancet Neurol. 2, 725-730 (2003
8. Fournier, N. M., Botterill, J. J., Marks, W. N., Guskjolen, A. J. & Kalynchuk, L. E. Impaired recruitment of seizure-generated neurons into functional memory networks of the adult dentate gyrus following long-Term amygdala kindling. Exp. Neurol. 244, 96-104 (2013
9. Berg, A. T. et al. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: Influences of etiology, syndrome, and seizure control. Pediatrics 114, 645-650 (2004
10. Berg, A. T., Zelko, F. A., Levy, S. R. & Testa, F. M. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: A prospective cohort study. Neurology 79, 1384-1391 (2012
11. Camfield, P., Camfield, C. & Pohlmann-Eden, B. Transition from pediatric to adult epilepsy care: A difficult process marked by medical and social crisis. Epilepsy Curr. 12, 13-21 (2012
12. Baraban, S. C., Dinday, M. T. & Hortopan, G. A. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat. Commun. 4, 2410 (2013
13. Hortopan, G. A., Dinday, M. T. & Baraban, S. C. Zebrafish as a model for studying genetic aspects of epilepsy. Dis. Model. Mech. 3, 144-148 (2010
14. Kayani, S. & Sirsi, D. The safety and tolerability of newer antiepileptic drugs in children and adolescents. J. Cent. Nerv. Syst. Dis. 4, 51-63 (2012
15. Large, C. H. et al. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: Implications for clinical use. Epilepsia 53, 425-436 (2012
16. Neal, E. G. et al. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurol. 7, 500-506 (2008
17. Oguni, H. et al. Treatment and long-Term prognosis of myoclonic-Astatic epilepsy of early childhood. Neuropediatrics 33, 122-132 (2002
18. Morrell, M. J. & RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 77, 1295-1304 (2011
19. Caraballo, R. H. et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 46, 1539-1544 (2005
20. Cook, M. J. et al. Prediction of seizure likelihood with a long-Term, implanted seizure advisory system in patients with drug-resistant epilepsy: A first in man study. Lancet Neurol. 12, 563-571 (2013
21. Fisher, R. et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51, 899-908 (2010
22. Cross, J. H. et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: Recommendations of the subcommission for pediatric epilepsy surgery. Epilepsia 47, 952-959 (2006
23. Loddenkemper, T. et al. Developmental outcome after epilepsy surgery in infancy. Pediatrics 119, 930-935 (2007
24. Moosa, A. N. et al. Long-Term functional outcomes and their predictors after hemispherectomy in 115 children. Epilepsia 54, 1771-1779 (2013
25. Mbuba, C. K., Ngugi, A. K., Newton, C. R. & Carter, J. A. The epilepsy treatment gap in developing countries: A systematic review of the magnitude, causes, and intervention strategies. Epilepsia 49, 1491-1503 (2008
26. Whorf, B. L. Language, Thought, and Reality: Selected Writings of Benjamin Lee Whorf (The Technology Press of Massachusetts Institute of Technology/John Wiley & Sons, Inc., 1956
27. Merlis, J. K. Proposal for an international classification of the epilepsies. Epilepsia 11, 114-119 (1970
28. Dreifuss, F. E. Classification of the epilepsies: Influence on management. Rev. Neurol. (Paris) 143, 375-380 (1987
29. [No authors listed] Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30, 389-399 (1989
30. Berg, A. T. et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia 51, 676-685 (2010
31. Berg, A. T. & Cross, J. H. Towards a modern classification of the epilepsies?. Lancet Neurol. 9, 459-461 (2010
32. Blume, W. T. et al. Glossary of descriptive terminology for ictal semiology: Report of the ILAE task force on classification and terminology. Epilepsia 42, 1212-1218 (2001
33. Dura-Trave, T., Yoldi-Petri, M. E. & Gallinas-Victoriano, F. Incidence of epilepsies and epileptic syndromes among children in Navarre, Spain: 2002 through 2005. J. Child Neurol. 23, 878-882 (2008
34. Eltze, C. M. et al. A population-based study of newly diagnosed epilepsy in infants. Epilepsia 54, 437-445 (2013
35. Freitag, C. M., May, T. W., Pfafflin, M., Konig, S. & Rating, D. Incidence of epilepsies and epileptic syndromes in children and adolescents: A population-based prospective study in Germany. Epilepsia 42, 979-985 (2001
36. Kurtz, Z., Tookey, P. & Ross, E. Epilepsy in young people: 23 year follow up of the British National Child Development Study. BMJ 316, 339-342 (1998
37. Camfield, C. S., Camfield, P. R., Gordon, K., Wirrell, E. & Dooley, J. M. Incidence of epilepsy in childhood and adolescence: A population-based study in Nova Scotia from 1977 to 1985. Epilepsia 37, 19-23 (1996
38. Doose, H. & Sitepu, B. Childhood epilepsy in a German city. Neuropediatrics 14, 220-224 (1983
39. Granieri, E. et al. A descriptive study of epilepsy in the district of Copparo, Italy, 1964-1978. Epilepsia 24, 502-514 (1983
40. Olafsson, E. et al. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: A prospective study. Lancet Neurol. 4, 627-634 (2005
41. Verity, C. M., Ross, E. M. & Golding, J. Epilepsy in the first 10 years of life: Findings of the child health and education study. BMJ 305, 857-861 (1992
42. Murray, C. J. et al. Disability-Adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2197-2223 (2012
43. GBD Compare. Institute for Health Metrics and Evaluation [online], http://viz.healthmetricsandevaluation.org/gbd-compare/ (2013
44. Diop, A. G., Hesdorffer, D. C., Logroscino, G. & Hauser, W. A. Epilepsy and mortality in Africa: A review of the literature. Epilepsia 46 (Suppl. 11), 33-35 (2005
45. Ding, D. et al. Premature mortality risk in people with convulsive epilepsy: Long follow-up of a cohort in rural China. Epilepsia 54, 512-517 (2013
46. Ngugi, A. K. et al. Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: Cross-sectional and case-control studies. Lancet Neurol. 12, 253-263 (2013
47. Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W. & Newton, C. R. Estimation of the burden of active and life-Time epilepsy: A meta-Analytic approach. Epilepsia 51, 883-890 (2010
48. Mung'ala-Odera, V. et al. Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya. Seizure 17, 396-404 (2008
49. Carter, J. A. et al. The reasons for the epilepsy treatment gap in Kilifi, Kenya: Using formative research to identify interventions to improve adherence to antiepileptic drugs. Epilepsy Behav. 25, 614-621 (2012
50. The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE Clinical Guidelines [online], http://www.nice.org.uk/nicemedia/live/13635/57779/57779.pdf (2013
51. Visser, A. M. et al. Paroxysmal disorders in infancy and their risk factors in a population-based cohort: The Generation R. Study. Dev. Med. Child Neurol. 52, 1014-1020 (2010
52. Uldall, P., Alving, J., Hansen, L. K., Kibaek, M. & Buchholt, J. The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch. Dis. Child. 91, 219-221 (2006
53. Zeiler, S. R. & Kaplan, P. W. Our digital world: Camera phones and the diagnosis of a seizure. Lancet 373, 2136 (2009
54. Gaillard, W. D. et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia 50, 2147-2153 (2009
55. Craven, I. J. et al. 3.0 T MRI of 2000 consecutive patients with localisation-related epilepsy. Br. J. Radiol. 85, 1236-1242 (2012
56. Jayakar, P. et al. Diagnostic test utilization in evaluation for resective epilepsy surgery in children. Epilepsia http://dx.doi.org./10.1111/ epi.12544.
57. Barkovich, A. J., Guerrini, R., Kuzniecky, R. I., Jackson, G. D. & Dobyns, W. B. A developmental and genetic classification for malformations of cortical development: Update 2012. Brain 135, 1348-1369 (2012
58. Bahi-Buisson, N. et al. Recurrent mutations in the CDKL5 gene: Genotype-phenotype relationships. Am. J. Med. Genet. A 158A, 1612-1619 (2012
59. Weckhuysen, S. et al. Extending the KCNQ2 encephalopathy spectrum: Clinical and neuroimaging findings in 17 patients. Neurology 81, 1697-1703 (2013
60. Carvill, G. L. et al. GRIN2A mutations cause epilepsy-Aphasia spectrum disorders. Nat. Genet. 45, 1073-1076 (2013
61. Harkin, L. A. et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 130, 843-852 (2007
62. Brunklaus, A. et al. The clinical utility of an SCN1A genetic diagnosis in infantile-onset epilepsy. Dev. Med. Child Neurol. 55, 154-161 (2013
63. Zuberi, S. M. et al. Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 76, 594-600 (2011
64. Klepper, J. GLUT1 deficiency syndrome in clinical practice. Epilepsy Res. 100, 272-277 (2012
65. Lancaster, E. & Dalmau, J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat. Rev. Neurol. 8, 380-390 (2012
66. Hacohen, Y. et al. Paediatric autoimmune encephalopathies: Clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J. Neurol. Neurosurg. Psychiatry 84, 748-755 (2013
67. Irani, S. R., Bien, C. G. & Lang, B. Autoimmune epilepsies. Curr. Opin. Neurol. 24, 146-153 (2011
68. Illingworth, M. A. et al. Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-Age children (FIRES). Dev. Med. Child Neurol. 53, 1053-1057 (2011
69. Nabbout, R. Autoimmune and inflammatory epilepsies. Epilepsia 53 (Suppl. 4), 58-62 (2012
70. Takahashi, Y. et al. Autoantibodies and cell-mediated autoimmunity to NMDA-Type GluR2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua. Epilepsia 46 (Suppl. 5), 152-158 (2005
71. Guidance for industry: E11 clinical investigation of medicinal products in the pediatric population. FDA [online], http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM073143.pdf (2000
72. Chiron, C., Dulac, O. & Pons, G. Antiepileptic drug development in children: Considerations for a revisited strategy. Drugs 68, 17-25 (2008
73. Glauser, T. A. et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N. Engl. J. Med. 362, 790-799 (2010
74. Chiron, C. et al. Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 356, 1638-1642 (2000
75. Wirrell, E. C. et al. Stiripentol in Dravet syndrome: Results of a retrospective U. S. study. Epilepsia 54, 1595-1604 (2013
76. Thanh, T. N. et al. Long-Term efficacy and tolerance of stiripentaol in severe myoclonic epilepsy of infancy (Dravet's syndrome). Arch. Pediatr. 9, 1120-1127 (2002
77. Glauser, T. et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 70, 1950-1958 (2008
78. Kato, M. et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia 54, 1282-1287 (2013
79. Miceli, F. et al. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of Kv7.2 potassium channel subunits. Proc. Natl Acad. Sci. USA 110, 4386-4391 (2013
80. European Medicines Agency [online], http://www.ema.europa.eu/ema/index. jsp?curl=pages/regulation/general/general-content-000029.jsp
81. Ceulemans, B. et al. Successful use of fenfluramine as an add-on treatment for Dravet syndrome. Epilepsia 53, 1131-1139 (2012
82. Lotte, J., Haberlandt, E., Neubauer, B., Staudt, M. & Kluger, G. J. Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome. Neuropediatrics 43, 17-21 (2012
83. Nicita, F. et al. Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: A pilot study. Seizure 23, 36-40 (2014
84. Porter, B. E. & Jacobson, C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 29, 574-577 (2013
85. Freitag, H. & Tuxhorn, I. Cognitive function in preschool children after epilepsy surgery: Rationale for early intervention. Epilepsia 46, 561-567 (2005
86. Jonas, R. et al. Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology 64, 746-750 (2005
87. Varadkar, S. et al. Rasmussen's encephalitis: Clinical features, pathobiology, and treatment advances. Lancet Neurol. 13, 195-205 (2014
88. Jansen, F. E., van Huffelen, A. C., Algra, A. & van Nieuwenhuizen, O. Epilepsy surgery in tuberous sclerosis: A systematic review. Epilepsia 48, 1477-1484 (2007
89. Wilfong, A. A. & Curry, D. J. Hypothalamic hamartomas: Optimal approach to clinical evaluation and diagnosis. Epilepsia 54 (Suppl. 9), 109-114 (2013
90. Sharma, S., Sankhyan, N., Gulati, S. & Agarwala, A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: A randomized controlled trial. Epilepsia 54, 481-486 (2013
91. Muzykewicz, D. A. et al. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia 50, 1118-1126 (2009
92. Kang, H. C., Lee, Y. M., Kim, H. D., Lee, J. S. & Slama, A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 48, 82-88 (2007
93. Suls, A. et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann. Neurol. 66, 415-419 (2009
94. Mullen, S. A. et al. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch. Neurol. 68, 1152-1155 (2011
95. Chang, P. et al. Seizure control by ketogenic diet-Associated medium chain fatty acids. Neuropharmacology 69, 105-114 (2013
96. Danial, N. N., Hartman, A. L., Stafstrom, C. E. & Thio, L. L. How does the ketogenic diet work?. Four potential mechanisms. J. Child Neurol. 28, 1027-1033 (2013
97. Masino, S. A. & Rho, J. M. Mechanisms of ketogenic diet action. In Jasper's Basic Mechanisms of the Epilepsies 4th edn (eds Noebels, J. L. et al.) (Bethesda National Center for Biotechnology Information, 2012
98. Morris, G. L. 3rd et al. Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 81, 1453-1459 (2013
99. Terra, V. C. et al. Vagus nerve stimulation in pediatric patients: Is it really worthwhile?. Epilepsy Behav. 31, 329-333 (2013
100. Krook-Magnuson, E., Armstrong, C., Oijala, M. & Soltesz, I. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat. Commun. 4, 1376 (2013
101. Paz, J. T. et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat. Neurosci. 16, 64-70 (2013
102. Austin, J. K. et al. Behavior problems in children at time of first recognized seizure and changes over the following 3 years. Epilepsy Behav. 21, 373-381 (2011
103. Caplan, R. et al. Psychopathology and pediatric complex partial seizures: Seizure-related, cognitive, and linguistic variables. Epilepsia 45, 1273-1281 (2004
104. Ott, D. et al. Behavioral disorders in pediatric epilepsy: Unmet psychiatric need. Epilepsia 44, 591-597 (2003
105. Oostrom, K. J. et al. Three to four years after diagnosis: Cognition and behaviour in children with epilepsy only'. A prospective, controlled study. Brain 128, 1546-1555 (2005
106. Oostrom, K. J. et al. Not only a matter of epilepsy: Early problems of cognition and behavior in children with epilepsy only-A prospective, longitudinal, controlled study starting at diagnosis. Pediatrics 112, 1338-1344 (2003
107. Jones, J. E., Siddarth, P., Gurbani, S., Shields, W. D. & Caplan, R. Cognition, academic achievement, language, and psychopathology in pediatric chronic epilepsy: Short-Term outcomes. Epilepsy Behav. 18, 211-217 (2010
108. Fosi, T., Lax-Pericall, M. T., Scott, R. C., Neville, B. G. & Aylett, S. E. Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult to treat epilepsy: Evidence of clinical benefit. Epilepsia 54, 2071-2081 (2013
109. Jensen, F. E. Epilepsy as a spectrum disorder: Implications from novel clinical and basic neuroscience. Epilepsia 52 (Suppl. 1), 1-6 (2011
110. Berg, A. T. Epilepsy, cognition, and behavior: The clinical picture. Epilepsia 52 (Suppl. 1), 7-12 (2011
111. Helmstaedter, C. et al. Disentangling the relationship between epilepsy and its behavioral comorbidities-The need for prospective studies in new-onset epilepsies. Epilepsy Behav. 31, 43-47 (2014
112. Pineda, E. et al. Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder. Epilepsy Behav. 31, 267-275 (2014
113. Kaufmann, R., Goldberg-Stern, H. & Shuper, A. Attention-deficit disorders and epilepsy in childhood: Incidence, causative relations and treatment possibilities. J. Child Neurol. 24, 727-733 (2009
114. Kantzer, A. K., Fernell, E., Gillberg, C. & Miniscalco, C. Autism in community pre-schoolers: Developmental profiles. Res. Dev. Disabil. 34, 2900-2908 (2013
115. Tuchman, R. Autism and social cognition in epilepsy: Implications for comprehensive epilepsy care. Curr. Opin. Neurol. 26, 214-218 (2013
116. Matsuo, M., Maeda, T., Sasaki, K., Ishii, K. & Hamasaki, Y. Frequent association of autism spectrum disorder in patients with childhood onset epilepsy. Brain Dev. 32, 759-763 (2010
117. Tuchman, R., Moshe, S. L. & Rapin, I. Convulsing toward the pathophysiology of autism. Brain Dev. 31, 95-103 (2009
118. Kang, J. Q. & Barnes, G. A common susceptibility factor of both autism and epilepsy: Functional deficiency of GABAA receptors. J. Autism Dev. Disord. 43, 68-79 (2013
119. Pineda, E. et al. Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann. Neurol. 74, 11-19 (2013
120. Sahin, M. Targeted treatment trials for tuberous sclerosis and autism: No longer a dream. Curr. Opin. Neurobiol. 22, 895-901 (2012
121. Zhang, D. Q., Li, F. H., Zhu, X. B. & Sun, R. P. Clinical observations on attention-deficit hyperactivity disorder (ADHD) in children with frontal lobe epilepsy. J. Child Neurol. 29, 54-57 (2014
122. Wandschneider, B. et al. Risk-Taking behavior in juvenile myoclonic epilepsy. Epilepsia 54, 2158-2165 (2013
123. Jackson, D. C. et al. The neuropsychological and academic substrate of new/recent-onset epilepsies. J. Pediatr. 162, 1047-1053.e1 (2013
124. Dunn, D. W., Austin, J. K. & Huster, G. A. Symptoms of depression in adolescents with epilepsy. J. Am. Acad. Child Adolesc. Psychiatry 38, 1132-1138 (1999
125. Ettinger, A. B. et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 39, 595-599 (1998
126. Jones, J. E. et al. Psychiatric comorbidity in children with new onset epilepsy. Dev. Med. Child Neurol. 49, 493-497 (2007
127. Williams, J. et al. Anxiety in children with epilepsy. Epilepsy Behav. 4, 729-732 (2003
128. Mazarati, A., Shin, D., Auvin, S., Caplan, R. & Sankar, R. Kindling epileptogenesis in immature rats leads to persistent depressive behavior. Epilepsy Behav. 10, 377-383 (2007
129. Guilfoyle, S. M., Wagner, J. L., Smith, G. & Modi, A. C. Early screening and identification of psychological comorbidities in pediatric epilepsy is necessary. Epilepsy Behav. 25, 495-500 (2012
130. Hesdorffer, D. C. et al. Risk factors for febrile status epilepticus: A case-control study. J. Pediatr. 163, 1147-1151.e1 (2013
131. Jones, J. E., Siddarth, P., Gurbani, S., Shields, W. D. & Caplan, R. Screening for suicidal ideation in children with epilepsy. Epilepsy Behav. 29, 521-526 (2013
132. Ben-Ari, Y., Khalilov, I., Kahle, K. T. & Cherubini, E. The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18, 467-486 (2012
133. Berg, A. T., Baca, C. B., Loddenkemper, T., Vickrey, B. G. & Dlugos, D. Priorities in pediatric epilepsy research: Improving children's futures today. Neurology 81, 1166-1175 (2013
134. Hamiwka, L. D., Singh, N., Niosi, J. & Wirrell, E. C. Diagnostic inaccuracy in children referred with first seizure: Role for a first seizure clinic. Epilepsia 48, 1062-1066 (2007
135. Austin, J. K. et al. Behavior problems in children before first recognized seizures. Pediatrics 107, 115-122 (2001
136. Fisher, R. S. et al. Seizure diaries for clinical research and practice: Limitations and future prospects. Epilepsy Behav. 24, 304-310 (2012
137. Iyer, A. & Appleton, R. Transitional services for adolescents with epilepsy in the U.K.: A survey. Seizure 22, 433-437 (2013
138. Thomson, L., Fayed, N., Sedarous, F. & Ronen, G. M. Life quality and health in adolescents and emerging adults with epilepsy during the years of transition: A scoping review. Dev. Med. Child Neurol. http://dx.doi.org/10.1111/ dmcn.12335.
139. Camfield, P. R., Gibson, P. A. & Douglass, L. M. Strategies for transitioning to adult care for youth with Lennox-Gastaut syndrome and related disorders. Epilepsia 52 (Suppl. 5), 21-27 (2011
140. Taniguchi, G., Watanabe, M., Watanabe, Y., Okazaki, M. & Murata, Y. Report of study on transitional medicine for epilepsy: Questionnaire survey of pediatric neurologists. No To Hattatsu 44, 311-314 (2012
141. Appleton, R. E., Chadwick, D. & Sweeney, A. Managing the teenager with epilepsy: Paediatric to adult care. Seizure 6, 27-30 (1997
142. Jurasek, L., Ray, L. & Quigley, D. Development and implementation of an adolescent epilepsy transition clinic. J. Neurosci. Nurs. 42, 181-189 (2010
143. Berg, A. T. et al. Mortality risks in new-onset childhood epilepsy. Pediatrics 132, 124-131 (2013
144. Nolan, K., Camfield, C. S. & Camfield, P. R. Coping with a child with Dravet syndrome: Insights from families. J. Child Neurol. 23, 690-694 (2008
145. Glauser, T. et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 54, 551-563 (2013
146. Vickrey, B. G., Hirtz, D., Waddy, S., Cheng, E. M. & Johnston, S. C. Comparative effectiveness and implementation research: Directions for neurology. Ann. Neurol. 71, 732-742 (2012
147. Leviton, A., Loddenkemper, T. & Pomeroy, S. L. Clinical practice guidelines and practice parameters for the child neurologist. J. Child Neurol. 28, 917-925 (2013
148. Dunkley, C. & Cross, J. H. NICE guidelines and the epilepsies: How should practice change?. Arch. Dis. Child. 91, 525-528 (2006
149. Nolan, S. J., Tudur Smith, C., Pulman, J. & Marson, A. G. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. Cochrane Database of Systematic Reviews, Issue 1, Art. No.: CD002217. http://dx.doi.org/10.1002/14651858. CD002217.pub2 (2013
150. Pal, D. K., Das, T., Chaudhury, G., Johnson, A. L. & Neville, B. G. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 351, 19-23 (1998
151. Concato, J., Shah, N. & Horwitz, R. I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N. Engl. J. Med. 342, 1887-1892 (2000
152. Hirtz, D. et al. Practice parameter: Evaluating a first nonfebrile seizure in children: Report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society. Neurology 55, 616-623 (2000
153. Gaillard, W. D. et al. Epilepsy imaging study guideline criteria: Commentary on diagnostic testing study guidelines and practice parameters. Epilepsia 52, 1750-1756 (2011
154. Kale, R. Global campaign against epilepsy: The treatment gap. Epilepsia 43 (Suppl. 6), 31-33 (2002
155. Wilmshurst, J. M. et al. Child neurology services in Africa. J. Child Neurol. 26, 1555-1563 (2011
156. English, M. & Opiyo, N. Getting to grips with GRADE-perspective from a low-income setting. J. Clin. Epidemiol. 64, 708-710 (2011
157. van Harssel, J. J. et al. Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders. Neurogenetics 14, 23-34 (2013
158. Bahi-Buisson, N. & Bienvenu, T. CDKL5-related disorders: From clinical description to molecular genetics. Mol. Syndromol. 2, 137-152 (2012
159. Kilstrup-Nielsen, C. et al. What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy. Neural Plast. 2012, 728267 (2012
160. Barcia, G. et al. Early epileptic encephalopathies associated with STXBP1 mutations: Could we better delineate the phenotype?. Eur. J. Med. Genet. 57, 15-20 (2014
161. Kato, M., Koyama, N., Ohta, M., Miura, K. & Hayasaka, K. Frameshift mutations of the ARX gene in familial Ohtahara syndrome. Epilepsia 51, 1679-1684 (2010
162. Kato, M. et al. A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome). Am. J. Hum. Genet. 81, 361-366 (2007
163. Striano, P., Coppola, G., Zara, F. & Nabbout, R. Genetic heterogeneity in malignant migrating partial seizures of infancy. Ann. Neurol. http://dx.doi.org/10.1002/ana.24061.
164. Barcia, G. et al. De novo gain of function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat. Genet. 44, 1255-1259 (2012
165. McTague, A. et al. Migrating partial seizures of infancy: Expansion of the electroclinical, radiological and pathological disease spectrum. Brain 136, 1578-1591 (2013
166. Fretheim, A., Schunemann, H. J. & Oxman, A. D. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines. Health Res. Policy Syst. 4, 27 (2006
167. Grimshaw, J., Eccles, M. & Tetroe, J. Implementing clinical guidelines: Current evidence and future implications. J. Contin. Educ. Health Prof. 24 (Suppl. 1), S31-S37 (2004
168. Katchanov, J. & Birbeck, G. L. Epilepsy care guidelines for low-And middle-income countries: From WHO mental health GAP to national programs. BMC Med. 10, 107 (2012.